THP-1 and Dictyostelium infection models for screening and characterization of anti-Mycobacterium abscessus hit compounds.
Mycobacterium abscessus (Mabs) possesses a great challenge to antimycobacterial therapy due to its innate resistance against most antibiotics. Mabs is able to grow intracellularly in human macrophages suggesting that intracellular models can facilitate drug discovery. Thus, we have developed two host cell models: a new high content screening method for Mabs growth in human macrophages and Dictyostelium discoideum infection model with the potential to simplify down-stream genetic analysis of host cell factors. A screen of 568 antibiotics against intracellular Mabs led to identification of two hit compounds with distinct growth inhibition. A collection of 317 human kinase inhibitors was analysed yielding three compounds with an inhibitory effect on mycobacterial growth strengthening the notion that host directed therapy can be applied for Mabs.